$AKER bottom Pr $2.79 $1 Million Initial Order to

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
$AKER bottom Pr $2.79

$1 Million Initial Order
to Supply PIFA Heparin/PF4 Products to China

akers-logo-blur.png
Website

Shares Outstanding: 4.95M
Float: 3.74M


yahoo_finance_en-US_s_f_p_191x21_finance_2x.png

10-Q 11/13/14
Summary

40 % Sell
850318709_barchart_logo1.jpg

Recent trades
599675067_stockwatch.jpg


Headlines


Wednesday, December 10, 2014
7:02 am Akers Biosciences received initial purchase order valued at $1 mln from NovoTek Therapeutics Inc. to supply PIFA Heparin PF4/Rapid Assay products in Mainland ChinaBriefing.com
Akers Biosciences Announces $1 Million Initial Order to Supply PIFA Heparin/PF4 Products to ChinaGlobeNewswire
Tuesday, December 2, 2014
Cannabis (MMJ) Breathalyzer Could Follow Vertical Path of Alcohol BreathalyzerAccesswire

Friday, November 21, 2014
AKERS BIOSCIENCES INC FinancialsEDGAR Online Financials

Tuesday, November 18, 2014
RedChip Issues Research Update on Akers BiosciencesGlobeNewswire

Thursday, November 13, 2014
AKERS BIOSCIENCES INC Files SEC form 10-Q, Quarterly ReportEDGAR Online
Akers Biosciences Announces Its Financial Results for Third Quarter 2014GlobeNewswire

Monday, November 10, 2014
Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial ResultsGlobeNewswire
Friday, November 7, 2014
AKERS BIOSCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online

Wednesday, October 29, 2014
AKERS BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibiEDGAR Online

Thursday, October 23, 2014
Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in ChinaGlobeNewswire
Wednesday, October 8, 2014
NETGEAR, Akers Biosciences, and TOP Ships to Appear on RedChip TV on BloombergGlobeNewswire

Monday, October 6, 2014
RedChip Announces Presentation Schedule for Its October 15-16 Online Investor ConferenceGlobeNewswire

Tuesday, September 16, 2014
Akers Biosciences Features on Global Broadcast & Online MediaGlobeNewswire

Wednesday, September 10, 2014
Police and Employers May Finally See Cannabis BreathalyzerAccesswire

Tuesday, September 9, 2014
RedChip TV Announces Lineup for This Week's Show on Fox Business and BloombergGlobeNewswire

Friday, August 15, 2014
AKERS BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online

Tuesday, August 12, 2014
AKERS BIOSCIENCES INC Files SEC form 10-Q, Quarterly ReportEDGAR Online

Monday, July 21, 2014
3 Stocks Advancing The Health Services Industryat TheStreet

Friday, July 18, 2014
3 Stocks Advancing The Health Services Industryat TheStreet
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Knee Treatment with Overture's Latest System

Updated Category News Views 312

Full Commercial Launch of the OvertureTi Knee Resurfacing System Overture Orthopaedics is making headlines as it proudly announces the full commercial launch of its advanced OvertureTi Knee Resurfacing System. This medical device targets early osteoarthritis and cartilage defects effectively, presenting a breakthrough for patients seeking alternatives to traditional joint...

Continue Reading
Elis SA: Key Insights on Recent Share Buyback Activities

Updated Category News Views 130

Elis SA's Recent Share Buyback Activities Elis SA has made a mark with its recent trading activities associated with its own shares, particularly highlighting a series of transactions carried out during a specified period. Overview of the Buyback Program As part of its strategic financial planning, Elis has engaged in a buyback program that has garnered attention. The...

Continue Reading
Kevin O'Leary's Essential Advice for Startups on Content Investment

Updated Category News Views 262

O'Leary: Tools Are Cheap, But Talent Isn't Entrepreneur and "Shark Tank" star Kevin O'Leary emphasizes a critical insight for startups: while the cost of creating digital content has drastically reduced, the true value comes from the talent that produces it. O'Leary shared his thoughts in a recent video, indicating that although the cost of technology has significantly...

Continue Reading
The St. James Reinvents Lacrosse with Spencer Ford at the Helm

Updated Category News Views 237

The St. James Strengthens Lacrosse Initiatives In an exciting development, The St. James has appointed Spencer Ford as the new Director of Lacrosse, ushering in a transformative approach to lacrosse for both boys and girls. With a vast wealth of experience spanning nearly twenty years, Ford is not only a seasoned professional player but also an accomplished coach and...

Continue Reading
Hudbay Minerals Celebrates Permit Approval for Copper World

Updated Category News Views 119

Hudbay Minerals Receives Final Permit for Copper World Project Hudbay Minerals Inc. (TSX, NYSE: HBM), a prominent player in the mining industry, has taken a significant step forward by securing the final major permit necessary for its Copper World project in Arizona. This milestone not only enhances the company’s operational capacity but also solidifies its commitment...

Continue Reading